Wednesday, November 14, 2018

The GE End Game: Bataan Death March or Turnaround Play?

It seems like ancient history, but it was just 2001, when GE was the most valuable company in the world, commanding a market capitalization in excess of $500 billion. The quintessential conglomerate, with a presence in almost every part of the global economy, it seemed to have been built to withstand economic shocks and was the choice for conservative investors, scared of the short life cycles and the volatile fortunes of its tech challengers. Unlike other aging companies like Sears that have decayed gradually over decades, GE's fall from grace has been precipitous , with the rate of decline accelerating the in the last two years. As a new CEO is brought in, with hopes that he will be a savior, it is the right time to both look back and look forward at one of the globe's most iconic companies.

GE: A Compressed History
GE's roots can be traced back to Thomas Edison and his invention of the light bulb. The company that Edison founded in 1878, Edison General Electric, was combined with two other electric companies to create General Electric in 1892. The company established its first industrial lab in 1900 and it would not be an exaggeration to say that it revolutionized not just the American home, with its appliances, but changed the way Americans live. For much of of the twentieth century, though, GE remained an appliance company, though it made forays into other businesses. It was in 1980, when Jack Welch became the CEO of the company, that the company started its march towards what it has become today.

The Market History
The first place to start, when looking at GE, is to see how markets have viewed it, over its life. Skipping over the first half of GE's life, the graph below looks at the growth (and recent decline) of GE's market capitalization over time:

As you can see, GE was a solid but unspectacular investment from 1950 to 1980, and exploded in value in the 1980s and 1990s, with Jack Welch at its helm, and reached its most valuable company in the world status in 2001. Under Jeff Immelt, his successor, the stock continued to do well, but it dropped with the rest of the market as the dot com bubble burst, but then recovered leaving into the 2008 crisis. That crisis was devastating for the company and while it did recover somewhat in the years after, the bottom has clearly dropped out in the last two years, with Jeff Flannery at the top of the company.

The Operating History
To get operating perspective on how the company has evolved over time, we looked at how GE"s key operating metrics (revenues, EBITDA, net income) have evolved since 1950:

In keeping with our earlier market cap assessment, between 1950 and 1970, GE was a good but not exceptional company, delivering solid revenue growth and decent margins. Under two CEOS, Reginald Jones in the 1970s and Jack Welch in the two decades thereafter, the company transformed itself. Jones helped the company navigate through the turbulent period of high inflation and oil prices, holding margins steady and delivering double digit revenue growth. Welch made himself the stuff of legend, by doubling margins and pushing the company to the top of the market cap ranks by the time he left the firm. His successor Jeff Immelt faced the unenviable task of following Welch, but managed to keep revenues growing and delivered high margins until 2008, when the bottom fell out for the company. 

The Business Mix Shift
To understand GE's current plight, we have to go back to Welch's tenure as CEO, when he remade the firm, by moving it away from its domestic and manufacturing roots and giving it a global and multi-business focus. GE's biggest leap during that period was into the financial services business, and one reason Welch was attracted to the financial services business was its capacity to generate high profits with relatively little investment. By the late 1990s, GE Capital was the engine driving GE's growth, accounting for almost 48% of revenues in 1998 and as you can see in the graph below, it continued to do so for much of the first decade of Immelt's stewardship:

In 2008, when the crisis hit financial service firms had, GE was significantly exposed, and in the years since, GE has retreated not just from the financial services business but also from its entertainment bets (with the sale of NBC to Comcast) and from the appliance business (now owned by Haier). GE's current business mix, broken down into more detail, is shown in the pie chart below:
GE Annual Report for 2017 (Invested Capital, allocated based upon assets by business)
Today, GE is in three businesses (aviation, healthcare and transportation) that have low growth and high profitability (margins and returns on capital), in three energy-related businesses (power, renewable energy and oil) with higher growth but low profitability (margins & returns on capital), one business (lighting) that is fading quickly and one (capital) that is declining, but dragging value down with it. Note also that the collective profits reported across businesses is  before corporate expenses and eliminations of $3.83 billion (not counting a one-time restructuring charge of $4.1 billion) that effectively wipe out about half of the operating profits. When computing return on capital, I allocated these expenses to the businesses, based upon revenues, and used a 25% effective tax rate, and while GE as a whole did not deliver a return that meets its cost of capital requirements in 2017, aviation, healthcare and transportation clear their hurdle rates by plenty. Replacing 2017 income in each business with a normalized value (computed using the average margins in each business between 2013 and 2017) improves the return on capital at the power and renewable energy businesses, but the overall conclusion remains the same. GE, as a company, does not look good, but it does have significant value creating businesses.

Corporate Life Cycle
While there are different ways of framing GE's current standing, I will use the corporate life cycle, since it encapsulates the challenges facing the company.

GE's light bulb moment might have been in Thomas Edison's lab in 1878, but at an official corporate age of 126 years, GE is an ancient company and its problems reflect its age. Other than renewable energy, all of GE's businesses are mature or declining, and by the laws of mathematics, GE itself is a mature to declining company.  Any story that you tell about GE going forward has to reflect this reality, and there are three possible ones that can lead to different values.
1. Break it up: If GE at its peak represented the glory of conglomerates, its current plight is a sign of how far conglomerates have fallen in the world. Across the world, multi business companies are finding themselves under pressure to break up and in many cases, their stockholders will be better off if they do. To gain from a break up, though, here are some of the things that have to be true. 
  • Separable businesses: The different businesses have to be separable, since leakages and synergies across businesses can make it more difficult to cleave off pieces to sell or spin off. On this count, GE is probably on safe ground, since its businesses (other than GE Capital) are self standing, for the most part, with little in terms of cross business effects. 
  • Willing buyers: There have to be potential buyers who are willing to pay prices for the pieces that exceed what they will generate as value for the holding company, as going concerns, and those higher prices either have to come from potential synergies or changed management. None of GE's businesses seem alluring enough to attract multiple bidders, willing to pay premium prices, and given GE's shaky bargaining position, it is more likely than not that a rush to unload businesses will do more harm than good. 
  • Corporate Waste (at HQ):  A large chunk of the corporate overhead has to viewed as wasteful, with a big drop in corporate expenses accompanying the breakup. How much of the corporate expense of $3.8 billion that GE reported in 2017 is wasteful and could be eliminated with targeted cost cuts? Looking at the breakdown of these expenses, just about $2.2 billion in for covering pension obligations and breaking up the company will not relieve the company of its contractual obligations. Some of the remaining $1.6 billion may be fat that can be cut, but even cutting the entire amount (which would be a tall order) will not turn the company around.
Since GE will be trying to sell these businesses to buyers today, this is a pricing and not a valuation exercise, and I have estimate a pricing for GE's businesses below, using an EBITDA recomputed using the average operating margin in each business over the last five years to compute operating income and allocating corporate expenses to the divisions, based upon revenues. To convert the EBITDA to an estimated value, I used the EV/EBITDA multiples of the peer group:
Download spreadsheet
If GE is able to get buyers to pay industry-level multiples of EBITDA for each of these businesses, it will be able to net about $103 billion for its equity investors, higher than the market capitalization on November 14 of $72 billion. The problem, though, is that fire sales of entire companies almost never deliver the expected proceeds, as buyers, recognizing desperation, hold back. In fact, GE's attempts to extricate itself from a portion of its Baker-Hughes investment in the last few days show that these sales will occur at a discount.

2. Retrench and Reshape: The second choice for GE is to retrench and perhaps renew itself, not as a growth company, but as a stable, high margin company in businesses where it has a competitive advantage. In broad terms, the roadmap for GE to succeed in this path is a simple one,  shrinking or selling off pieces of its low-margin businesses, exiting the capital business and consolidating its presence in the aviation, healthcare and transportation businesses. To get a better sense of what the businesses would be worth, as continuing operations, I valued each of GE's business, using simplistic assumptions: I used the sector cost of capital for each business, set growth in the next five years equal to revenue growth in each of GE's businesses in the last five years and normalized operating income based upon the average operating margin that each of GE's businesses have delivered over the last five years:
Download spreadsheet
The value that I derive for equity is lower than the $103 billion that I estimated in the last section, but it does not require any near term fire sales at discounts. There are two big challenges that GE will face along the way. The first is that GE is saddled with a significant debt obligation, a legacy of GE Capital, that will not fade away quickly, and the debt obligations represent a clear and present danger to the firm.  One reason for the rapid drop in GE's stock price in the last few weeks has been the deterioration in the company's credit standing, as can be seen in the rising default spreads for the company in the CDS market.

The reason that GE is trying to sell some of its stake in Baker and Hughes to pay down debt, but bond markets are skeptical, with good reason. The second is that GE Capital is now more burden than benefit to investors. In the valuation table, note that the value that I have estimated for GE Capital's operations ($27 billion) is much lower than GE Capital debt ($51 billion); in fact, I derive very similar results in the pricing. Put differently, in my valuation, I foresee the cost of exiting GE capital to be $24 billion in today's terms, but spread out over time.  If GE can navigate its way through its debt payments to becoming a more focused company, with constrained ambitions, it could survive and reclaim its place as a holding for a conservative value investor.

3. Reincarnate (or the Bataan Death March): There is a third option that GE shareholders have to hope and pray that GE does not take, where the company tries to recapture its old glory, throwing caution to the winds and reinvesting large amounts in new businesses, or worse still, large acquisitions. While there is no indication that Larry Culp, GE's new CEO, has grandiose plans for the company, that may be because the company is in crisis today. If as the crisis passes, Culp is tempted to make himself the second coming of Jack Welch, the company will follow the path of other aging companies that refuse to act their age, spending billions on cosmetic surgery (acquisitions) before finally capitulating. If there is a role model that Mr. Culp should follow, it is less that of Steve the Visionary, and more that of Larry the Liquidator

General Lessons
Given its age, it should come as no surprise that GE has been the subject of more case studies than perhaps any other company in the world. In its earlier days, it was used as an example of professional management, and during Jack Welch's years, it was held up as an illustration of how aging manufacturing companies can remake themselves, with enlightened management at the top. Now that it is in trouble, I think that we look back at the last four decades and draw a different set of lessons:
  1. Conglomeration was, is and always will be a bad idea: I never understood the allure of conglomerates, even in their heyday. Only a corporate strategist could argue that combining companies in different businesses under one corporate umbrella, paying hefty premiums along the way to acquire these holdings, creates value, ignoring the logic that you and I as stockholders can create our own diversified and customized portfolios, without paying the same premium. If there is a lesson to learn from GE's fall from grace, it is that even the best conglomerates are built on foundations of sand. Note, though, that while this lesson may be learned for the moment, it will be forgotten soon, as are most other business lessons are, and we will surely repeat the cycle again in the future.
  2. Complexity has a cost: As I was going through GE's annual report, I was reminded again of why I have always described my vision of hell as having to value GE over and over and over again, for eternity. This company, through its actions and by design, made itself into one of the most complex companies in history, operating in dozens of businesses and across the world, with GE Capital acting as the cherry on the complexity cake, a gigantic financial service firm embedded in a large conglomerate. While that complexity served GE well in its glory days, allowing it to hide mistakes from sloppy acquisition practices and bets gone bad, it has bedeviled the company since 2008. Investors trying to navigate their way through the company's financials often give up and move on to easier prey. It may be too late for GE to do much about this problem, but as Asian companies rise in market capitalization, you are seeing new complex behemoths coming into play across the world.
  3. Easy money has a catch: I know that 20/20 hindsight is both easy and unfair, but GE's experiences with GE Capital bring home an age-old business truth that when a business looks like it can make you easy money, there is always a catch. Jack Welch initial foray into and subsequent expansion of GE Capital was built on the allure that it was a lot easier to make money in financial services than in manufacturing. From the perspective of having limited capital investment and growing quickly, that was true, but financial service firms through history have always had periods of plenty interspersed with bouts of gut-wrenching and intense pain, when borrowers start defaulting and capital markets freeze up. By making GE Capital such a big part of GE, Welch bet the farm on its continued success, and that bet went sour in 2008.
  4. The Savior CEO is a myth: I come to neither bury nor praise Jack Welch, but notwithstanding the fact that he has been gone almost two decades from the firm, GE remains the house that Jack built. Since Welch got the glory that came from GE's rise in the last twenty years of the last century, he deserves a portion of the blame for what has happened since. Don't get me wrong! Jack Welch was an inspirational top manager, a man with vision and drive, but he was also an imperial CEO, who made his board of directors a rubber stamp for his actions. As we look at a new generation of successful companies, this time in the technology space (the FANG stocks and the Chinese giants), with visionary founders at the top, it is worth remembering that power left unchecked in any person (no matter how smart and visionary) is dangerous.
The Bottom Line
As many of you know, I believe that every valuation has to have a story. With some companies, like Amazon and Google, the story is uplifting and optimistic, and the valuations follow, but they still might not be good investments, since their prices may be even higher. My story for GE is not an upbeat one, but if it (and its management) acts its age, accepts that slower or no growth is what lies in the future and does not over reach, it is a good investment. I believe that the market has over corrected for GE's many faults, and at the current stock price, that it is significantly under valued. I will buy GE, but I will do so with open eyes, not expecting (or wanting) dividends to be paid until the debt gets paid down and the company exits the capital business with as much grace (and as few costs) as it can muster. 

YouTube Video


Monday, October 29, 2018

An October Surprise? Making Sense of the Market Mayhem!

I don't know what it is about October that spooks markets, but it certainly feels like big market corrections happen in the month. As stocks have gone through contortions this month, more down than up, like many of you, I have been looking at my portfolio, wondering whether this is the crash that the market bears have been warning me about since 2012, just a pause in a continuing bull market or perhaps a prognosticator of economic troubles to come. If you are expecting me to give you the answer in this post, I would stop reading, since reading market tea leaves is not my strength. That said,  I have been wrestling with what, if anything, I should be doing, as an investor, in response to the market movements. As in previous market crises, I find myself going back to a four-step process that I hope gets me through with my sanity intact. 

Step 1: Hit the pause button
The first casualty of crisis is good sense, as I mistake my panic response for instinct, and almost every action that I feel the urge to take in the heat of the moment is driven by fear and greed, not reason. No amount of rational thinking or studying behavioral finance will cure me of this affliction, since it is part of my make up as a human being, but there are three things that I find help me manage my reactions:
  1. Take a breath:  When faced with fast-moving markets, I have to force myself to consciously slow down. It helps that I don't work as a trader or a portfolio manager, since part of your job is to look like you are in control, even when you are not. 
  2. Turn off the noise: Turn back the clock about four decades and assume that you were a doctor, a lawyer or a factory worker with much of your wealth invested in stocks. If markets were having a bad day, odds were that you would not even have heard about it until you got home and turned on the news, and even then, you would have been fed scraps of information about Dow, perhaps a 2-minute discussion with a market expert, and you would have then turned on your favorite sitcom. Today, not only can you monitor your stocks every moment of your working day, you can trade on your lunch break and stream CNBC on to your desktop. That may make you a more informed investor, or at least an investor with more information, but I am not sure that constant feedback is healthy for your portfolio, especially in periods like this one. I don't have a Bloomberg terminal on my desk, a ticker tape running on  my computer or stock apps on my phone, and I am happy that I don't during periods like this month.
  3. Don't play the blame game: Every market correction has its villains, and investors like to tag them. Central banks and governments are always good targets, since they have few defenders and have a history of triggering market meltdowns. The problem that I find with assigning blame to others is that it then relieves me of any responsibility, even for own mistakes, and thus makes it impossible to learn from them and take corrective action.
Step 2: Assess the damage
In an age of instant analysis and expert opinion, it is easy to get a skewed view of not only what is causing the market damage, but also where that damage is greatest. In my (limited) reading of market analyses during the last four weeks, I have seen at least a half a dozen hypotheses about the stock swoon, from it being the Fed's fault (as usual) to a long overdue tech company correction to it being a response to global crises (in Italy and Saudi Arabia). In keeping with the old adage of "trust, but verify", I decided to take a look at the data to see if there are answers in it to these questions. 

1.The Fed's fault? 
As those of you who read my blog know well, I believe that the Fed has far less power than we think it does to set interest rates, but it is a convenient bogeyman. One explanation for the stock drop that has been making the rounds is that it is fear that Fed will raise rates too quickly in the future, that is causing stocks to swoon. Is that a plausible story? Yes, but if it is the reason for the market decline, you would have a difficult time explaining the movement in interest rates during October 2018:
Source: Federal Reserve (FRED)
As stocks have gone through their pains since October 1, treasury bill and bond rates have remained steady, which would make little sense if the expectation is that they will rise in the near future. After all, if investors expect rates to rise soon, those rates will start going up now and not on cue, when the Fed acts.

There is the possibility that this could be a delayed reaction to rates having gone up over the year already, with the 10-year treasury bond rate moving from 2.41% at the start of the year to 3.06% at the start of October 2018 and to a flattening yield curve (which has historically been a precursor to slower economic growth). Note though, that much of this movement in interest rates happened in the first six months of the year and you would need a reason for why stock prices would be moving four months later.

2. A Tech Meltdown?
My view, based upon what I had been hearing and reading, and before I looked at the data, was that the October 2018 stock drop was being caused by tech companies, in general, and the large tech companies, especially the FANG+Apple combination, specifically. To see if this is true, I looked at the returns on all US stocks, classified by sectors (as defined by S&P), in October, in the year to date and for 1-year and 5-year time periods.
US Sector Market Cap Change. Source: S&P Capital IQ
I know that the S&P sector classifications are imperfect, but my priors seem to be wrong. While information technology, as a group, lost 8.76% of aggregate market capitalization in October 2018, the three worst sectors in the US market were energy, industrials and materials, all of which lost much more, in percentage terms, than technology. In fact, the two sectors that did the best were consumer staples and utilities, with the latter's performance also providing evidence that it is not interest rate fears that are primarily driving this market correction. 

I have argued that, unlike two decades ago, technology companies now are now a diverse group, and many of them don't fit the "high growth, high risk" profile that people seem to still automatically give all tech companies. Using the terminology of corporate life cycles, tech companies  run the gamut from old tech to middle-aged tech to young tech, and I have looked at how tech companies in each age grouping in the graph below (age is defined, relative to year of founding):

The median percentage change, in both October 2018 and YTD 2018,  in market capitalization was greatest at the youngest tech companies. The median percentage change becomes smaller for older tech companies, in October 2018, but the effect for the four highest age classes is more mixed for the YTD numbers. That said, a much smaller median percentage change at the largest tech companies has a much biggest effect on the market, because of the market capitalization of these companies. That is the reason I look at the FANG stocks and Apple in the table below:
While the percentage change in stock prices at these companies is in line with the market drop, if Apple is included in the mix, the five companies collectively lost a staggering $276 billion in market capitalization between October 1 and October 26. accounting for almost 11.7% of the overall drop in market capitalization of US stocks. While investors in these stocks may feel merited in complaining about their losses, I would draw their attention to the third column, where I look at what these stocks have done since January 1, 2018, with the losses in October incorporated. Collectively, these five companies have added almost $521 billion in market capitalization since the start of the year, and without them, the overall market would have been down substantially.

3. A Correction in Overvalued Stocks?
For some value investors who have argued that investors were pushing up some stocks to unsustainable levels, the market correction has been vindication, a sign that the market is correcting its pricing mistakes and marking down the stocks that it had over priced the most. That may be plausible, and to see if it holds, I broke all US stocks, at the start of October, based upon PE ratios into six groupings (low to high PE and a separate one for negative earnings companies):
PE Ratio at start of October 2018, using trailing 12 month earnings
If the selective correction argument is correct, you should expect to see the highest PE ratio and negative earnings companies drop the most in value and the companies with the lowest PE ratios be less affected. While negative earnings stocks have seen the market correction, during October 2018, there is no pattern across the other PE classes. In fact, the lowest PE ratio companies had the second worst record, in terms of price performance, among the groupings. 

4. A US Problem?

One of the lessons of the last decade is that much as countries would like to disconnect from the rest of the world and chart their own pathway to economic prosperity, they are joined at the hip by globalization, with crisis in one part of the world quickly affecting economies and markets in other parts. In October 2018, we had our share of global shocks, with the standoff between Italy and the EU and Saudi Arabia's Khashoggi problem taking top billing. To see how the market correction has played out in world markets, I broke global markets down into broad regional groupings and arrived at the following:
Source: S&P Capital IQ, based upon headquarters geography
Note that these returns are all in US dollars, reflecting both the performance of the market and the currencies of each region. Asia seems to have been hit the worst this month, with China, Small Asia (South East Asia, Pakistan, Bangladesh) and Japan all seeing double digit declines in aggregate market capitalization. Latin America has had the best performance of the regional groupings, with the election surprise in Brazil driving its markets upwards during the month.  The year-to-date numbers do tell a bigger story that has been glossed over in analysis. For much of 2018, the US market & economy has diverged from the rest of the globe, posting solid numbers (prior to October) whereas the rest of the world was struggling. It is possible that we are seeing an end to that divergence, suggesting that the US markets will move more closely with the other global markets going forward.

5. Panic Attack?

One of the more striking features of the markets during October 2018 has been that the stock market retreat, while substantial, has, for the most part, been orderly. In a panic-driven stock market sell off, you usually see a surge in government bond prices (and a drop in rates), a general flight to quality (US $ and safer companies) and a rise in the price of gold. As we noted in the earlier section, the market drop does not seem to be smaller at larger and more profitable companies, and government bond rates have not dropped. In addition, while the US dollar has had a strong year so far, especially against emerging market currencies, it generally did not see a flight to it in October 2018:

The dollar strengthened mildly against almost every currency during the month, and the only currency where there was a big move was against the Brazilian Reai, where it weakened, again on political news in Brazil. Note again that the market correction may be, at least partly, a delayed reaction to the strength of the US dollar leading into October, but the timing is still difficult to explain. Finally, I looked at gold prices in October 2018, in conjunction with bitcoin, since the latter has been promoted as millennial gold:
It has been a good month for gold, with prices up 4.44%, though there is little sign of panic buying pushing up prices. It may be a little unfair to be passing judgment on Bitcoin, after one crisis, but if it is millennial gold, either millennials are unaware that there is a stock market sell off or they do not care. 

Step 3: Review the fundamentals
With the assessment of market pain behind us, we can turn to looking at the fundamentals, again looking for clues in why stocks have had such a tough month. While almost every factor affects stock prices, the effects have to show up in one of four places for fundamental value to change significantly: a shock to base year earnings or cash flows, a change in expected earnings/cash flow growth, a increase in the risk free rate or a change in the price of risk:

Since treasury bond rates have been stable through much of the month, I am going to look at one of the other three variables as the potential culprit.
  1. Base Year Earnings/Cashflows: The earnings reports that have come out for companies in diverse sectors in the last two weeks seem to reinforce the strong earnings story. While there were a few like Caterpillar and 3M that reported headwinds from a stronger dollar, both companies also conveyed the message that they were able to pass the higher costs through to the customers.
    On the cash flow front, there were no high profile cessations of buybacks or dividends, and all signs point to the market delivering and perhaps beating the earnings and cash flows that we have estimated for 2018.
  2. Earnings Growth: This is a trickier component, since it is driven as much by actual data, as it is by perception. At the start of the year, the expectation that earnings growth would be strong for this year, helped both the tax law changes of last year and a strong economy. That growth has been delivered, but it is possible that investors are now doubtful about the sustainability of that earnings growth. That has not shown up yet in forecasted growth for next year, but it bears watching.
  3. Price of Equity Risk (Equity Risk Premium): If you have been reading my blog for a while, you are probably aware of my implied equity risk premium calculation, one that backs out a price of equity risk (equity risk premium) from the level of the index, expected cash flows and a growth rate. Holding cash flows and growth rate fixed for October, I have computed the implied equity risk premium by day. 

End of DayUS 10-yr T.BondS&P 500Implied ERPSpreadsheet
If cash flows and expected growth have not changed over the month, the price of equity risk has jumped from 5.38% at the start of the month to the 5.89% on October 26, putting it at the high end of equity risk premiums in the last decade.

You could attribute the higher equity risk premiums to global crises (in Italy and Saudi Arabia) but that would be a reach since the increase in risk premiums predates both crises. If you do lower expected earnings growth going forward, perhaps reflecting a delayed response to the stronger dollar and higher rates, the equity risk premium will drop. In fact, halving the expected growth rate from 2019 on from the current estimate of 7.29% to 4.71% (the compounded average annual earnings growth rate over the last 10 years) reduces the equity risk premium to 5.28%, but even that number is a healthy one, relative to historic norms. The bottom line is that, at least by my calculations, I am estimating an equity risk premium that seems fair, given macro and micro fundamentals and my risk preferences.

Step 4: Investment Action
One of the biggest perils of being reactive in a  crisis is that it can knock you off your investment game and cause you to abandon your core philosophy. I don't believe that there is one investment philosophy that is right for every one, but I do believe that there is one that is right for you, and shifting away from it is a recipe for bad results. I am a “value” investor, though my definition of value is different from old-time value investing in two ways:
  1. Under valued stocks can be found across sectors and the life cycle: I believe that we should try to assess fair value, not a conservative estimate of value, and that the value should include expected value added from future growth. To the critique that this is speculative, my answer is that everything other than cash-in-hand requires making assumptions about the future, and I am willing to go the distance. That is why, at different points in time, you have seen Twitter and Facebook in my portfolio in the past and may well see Netflix and Tesla in the future (just not now).
  2. Intrinsic value can change over time: I believe that intrinsic value is a dynamic number that changes over time, not only because new information may come out about a company. but also because the price of equity risk can change over time. That said, intrinsic values generally change less than market prices do, as mood and momentum shift. This has been a month of significant price drops in many companies, but assuming that they are therefore more likely to be under valued is a mistake, since the intrinsic values of these companies have also changed, because the ERP that I will be using to value the stocks on October 26, 2018, will be 5.89%, much higher than the 5.38% at the start of the month.
Given my philosophy and a reading of the data, here is what I plan to do.

  1. No change in asset allocation:  I am not changing my asset allocation mix in significant ways, since I don't see a fundamental reason to do so. 
  2. Revisit existing holdings: I normally revalue every company in my portfolio at least once a year, but after a month like this one, I will have to accelerate the process. Put simply, I have to make sure that at the current price for equity risk, and given expected cash flows, that my buys still remain buys and the sells remain sells.
  3. Bonus from short sales: I do have a portion of my portfolio that benefits from a sell off, primarily in short sales and those have provided partial offsets to my losses. I did sell short on Amazon and Apple at the start of the month, and while I would like to claim prescience, it was pure luck on timing, and the market downdraft during the month has helped me. 
  4. Check out the biggest market losers: I plan to take a closer look at the stocks that have been pummeled the most during the month, including 3M and Caterpillar, to see if they are cheap at October 26 prices, and using an October 26 ERP in my valuation. 
Please note that this is not meant to be investment advice and your path back to investment serenity may be very different from mine! 

YouTube Video

Tuesday, October 16, 2018

High and higher: The Money in Marijuana!

In 1992, when Bill Clinton was running for president of the United States, and was asked whether he had ever smoked marijuana, he responded that he had, but that he did not inhale, reflecting the fear that being viewed as a weed-smoker would lay low his presidential ambitions. How times have changed! Today, smoking marijuana recreationally is legal in nine states, and medical marijuana in twenty nine states, in the United States. Outside the United States, much of Europe has always taken a much more sanguine view of cannabis, and on October 17, 2018, Canada will become the second country (after Uruguay) in the world to legalize the recreational use of the product. In conjunction with this development, new companies are entering the market, hoping to take advantage of what they see as a “big” market, and excited investors are rewarding them with large market capitalizations. I have never smoked marijuana, but on my daily walks on the boardwalks of San Diego, I have been inhaling a lot of second-hand smoke, leaving me a little light headed as I write this post. So, read on at your own risk!

The Macro Big Picture
While there is much to debate about how this market will evolve over time, and whether investors and businesses can make money of that evolution, there is one fact that is not debatable. The cannabis market will be a big one, in terms of users and revenues, drawing in large numbers of the population. To get a sense of the growth in this business, consider some nascent statistics from the soon-to-be legalized Canadian recreational market:
  1. Lots of people smoke weed: According to the Canadian national census, 42.5% of Canadians have tried Marijuana and about 16% had used it in the recent past (last 3 months), with the percentages climbing among younger Canadians, where one in three being recent users.
  2. And spend money to do so: The total revenues from recreational marijuana sales in Canada alone is expected to be $7-8 billion in 2020 and grow at a healthy rate after that. Some of this will represent a shifting from the illegal market (estimated at close to $5 billion in 2017) and some of it will represent new users drawn in its legal status.
There is also information that can be gleaned about the future of this business from the states in the United States that have legalized marijuana.
  1. In California, where legalization occurred at the start of 2018, revenues from cannabis are expected to be about $3.4 billion in 2018, but that is not a huge jump from the $3 billion in revenues in the illegal market in 2017. One reason, at least in California, is that legal marijuana, with testing, regulation and taxes, is much more expensive than that obtained in the illegal markets that existed pre-legalization. 
  2. In Colorado, where recreational marijuana use has been legal since 2014, the revenues from selling marijuana have increased from $996 million in 2015 to $1,25 billion in 2016 to $1,47 billion in 2017, representing solid, but not spectacular, growth. Marijuana-related businesses in Colorado have benefited from the revenue growth but have, for the most part, been unable to convert that growth into solid profits, partly because of the regulatory and tax overlay that they have had to navigate. 
With the limited data that we have from both Canada and the US states that have legalized marijuana, here are some general conclusions that come to mind.
  1. The illegal marijuana market will persist after legalization: The illegal weed business will continue, even after legalization, for many reasons. One is that legalization brings costs, regulations and taxes, which make the cost of legal weed higher than its illegal counterpart. The other is cultural, where a segment of long-time weed smokers will be reluctant to give up their traditional ways of acquiring and using weed. From a business standpoint, this will mean that the legal weed businesses will have to share the market with unregulated and untaxed competitors, reducing both revenues and profitability.
  2. There will be growth in recreational marijuana sales, but it will not be exponential: For those who are expecting a sudden surge of new users, as a result of legalization, the results from the parts of the world that have legalized should be sobering. In most of these parts, to the extent that society and law enforcement had already turned a blind eye to enforcing marijuana laws before legalization, there was no sea change in legal consequences from weed smoking. 
  3. The medical marijuana market growth will be driven more by research indicating its value in health care than by popularity contests. The bad news is that this will require navigating the time-consuming and cash-burning FDA regulatory approval process but the good news is that once approved, there is less likely to be pushback, cultural or legal, against its use. It is a safe prediction that medical marijuana will be legal in all of the United States far sooner than recreational marijuana.
  4. Federal laws matter: If you are a company in the weed business in one of the nine states that has legalized recreational marijuana, you still face a quandary. While your operations may be legal in the state that you operate in, you are at risk any time your operations require you to cross state lines and as we noted with Colorado businesses, when you pay federal taxes. Since most financial service firms operate across state borders and are regulated by Federal entities, it has also meant that even legal businesses in this space have had trouble raising funding or borrowing money from banks.
In spite of all of these caveats, there is optimism about growth in this market, with the more conservative forecasters predicting that global revenues from marijuana sales will increase to $70 billion in 2024, triple the sales today, and the more daring ones predicting close to $150 billion in sales.

The Business Question
If the marijuana market is likely to grow strongly, it should be a good market to operate a business in, right? Not all big businesses are profitable or value creating, since for a big business to be value creating, it has to come with competitive advantages or barriers to entry. If you are an investor in this space, you also have to start thinking about how companies will set themselves apart from each other, once the business matures. To see how companies in this business will evolve, it is important that you separate the recreational from the medical cannabis businesses, since each will face different challenges.

I. Recreational Cannabis
Like tobacco and alcohol, the recreational marijuana business will grow with a wink and a nod towards its  side costs, and potential to be a gateway to more potent and addictive substances. Like tobacco and alcohol, marijuana will face both constraints on who it can be sold to, as well as lawsuits down the road. Before you take issue with me for taking a negative view of marijuana, note that this is not a bad path to follow, given that tobacco and alcohol have been solid money-makers for decades. The question then becomes whether, like alcohol and tobacco, cannabis will become a brand-name driven business, where having a stronger brand name allows the winners to charge higher prices and earn better margins, or whether it devolves into a commodity business, where there is little to differentiate between the offerings of different companies, leading to commoditization and low margins. If it is the former, the most successful businesses in the space will bring marketing and branding skills to the table and if it is the latter, it will be economies of scale, and low-cost production that will be the differentiator.

II. Medical Cannabis
The medical marijuana business will more closely resemble the pharmaceutical business, where you will have to work with health care regulations and economics. Success in this business will come from finding a blockbuster cannabis-based drug that can then be sold at premium prices. If our experience with young pharmaceutical and biotech companies is an indicator, this would suggest that to succeed in this business, a company will need continued access to capital from investors with patience, a strong research presence and an understanding of the regulatory approval process. The company will also generate more value in health care systems where drug companies have pricing power, making the US market a much more lucrative one than the Canadian one. The differences between the two businesses are stark enough that you can argue that it will be difficult for a company to operate in both businesses without running into problems, sooner or later.

Investment considerations
So, should you invest in this business or stay away until it becomes more mature? While there is an argument for waiting, if you are risk averse, it will also mean that you will lose out on the biggest rewards. If you are exploring your options today, you have to start by assessing your investment choices and pick the one that you are most comfortable with.

The Investment Landscape
This is a young and evolving business, with the  Canadian legalization drawing more firms into the market. Not only are the companies on the list of public companies in the sector recent listings, but almost all of them have small revenues and big losses. While that, by itself, is likely to drive away old time value investors, it is worth noting that at a this early stage in the business life cycle, these losses are a feature, not a bug. Looking at just the top 10 companies, in terms of market cap, on the cannabis business, here is what I see:
Largest Publicly Traded Cannabis Companies- October 2018 
Note that the biggest company on the list is Tilray, a company that went publicly only a few months ago, with revenues that barely register ($28 million) and operating losses. Tilray made the news right after its IPO, with its stock price increasing ten-fold in the weeks after, before losing almost half of its value in the weeks after. Canopy Growth, the largest and most established company on this list, has the highest revenues at $68 million. More generally, Canadian companies dominate the list and all of them trade at astronomical multiples of book value.

As new companies flock into the market, the list of publicly traded companies is only going to get longer, and at least for the foreseeable future, most of them will continue to lose money. Adding to the chaos, existing companies that have logical reasons to enter this business (tobacco & alcohol in the recreational and pharmaceuticals in the medical) but have held back will enter, as the stigma of being in the business fades, and with it, the federal handicaps imposed for being in the business. Put simply, this business, like many other young and potentially big markets, seems to be in the throes of what I called the big market delusion in a post that I had about online advertising companies a few years ago.

Trading and Investing
Like all young businesses, this segment is currently dominated by trading and pricing, not investing and valuation. Put differently, companies are being priced based upon the size of the potential market and incremental information. Put simply, small and seemingly insignificant news stories will cause big swings in stock prices. Thus, there is no fundamental rationale you can give for why Tilray’s stock has behaved the way it has since it's IPO. It is driven by mood and momentum. If you are a good trader, this is a great time to play the game, since you can use your skills at detecting momentum shifts to make money as the stock goes up and again as it goes down. Since I am a terrible trader, I will leave it up to to you to decide whether you want to play the game.

If you are an investor, you want to invest on the expectation that there is more value in these companies than you are paying up front, for your equity stake. As I see it, here are your choices:
  1. The Concentrated Pick: Pick a stock or two that you believe is most suited to succeed in the  business, as it matures. Thus, if you believe that the business is going to get commoditized and that the winner will be the one with the lowest costs, you should target a company like Canopy Growth, a company that seems to be pushing towards making itself the low-cost leader in the growth end of the business. If, in contrast, you believe that this is a business where branding and marketing will set you apart, you should focus on a company that is building itself up through marketing and celebrity endorsements. To succeed at this strategy, you have to be right on both your macro assessment and your company pick, but if you are, this approach has the potential to have the biggest payoff. 
  2. Spread your bets: If your views about how the business will evolve are diffuse, but you do believe that there will be strong overall revenue growth and ultimate profitability, you can buy a portfolio of marijuana stocks. In fact, there is an ETF (MJ) composed primarily of cannabis-related stocks, with a modest expense ratio; its ten biggest holdings are all marijuana stocks, comprising 62% of the portfolio. The upside is that you just have to be right, on average, for this strategy to pay off, but the downside is that these companies are all richly priced, given the overall optimism about the market today. You also have to worry that the ultimate winner may not be on the list of stocks that are listed today, but a new entrant who has not shown up yet. If you are willing to wait for a correction, and there will be one, you may be able to get into the ETF at a much more reasonable price.
  3. The Indirect Play: Watch for established players to also jump in, with tobacco and alcohol stocks entering the recreational weed business, and pharmaceutical companies the medical weed business. You may get a better payoff investing in these established companies, many of which are priced for low growth and declining margins. One example is Scott’s Miracle-Gro, for instance, which has a growing weed subsidiary called Hawthorne Gardening. Another is GW Pharmaceuticals that has cannabis-based drugs in production for epilepsy and MS.
It may be indication of my age, but I really don’t have a strong enough handle on this market and what makes it tick to make an early bet on competitive advantages. So, I will pass on picking the one or two winners in the market. Given how euphoric investors have been since the legalization of weed in Canada in pushing up cannabis stock prices, I think this is the wrong time to buy the ETF, especially since sector is going to draw in new players.  That leaves me with the third and final choice, which is to invest in a company that is not viewed as being in the business but has a significant stake in it nevertheless. At current stock prices, neither Scott Miracle-Gro nor GW Pharmaceuticals looks like a good bet (I valued Scott Miracle-Gro at about $55, below its current stock price of $70.), but I think that my choices will get richer in the years to come.  I can wait, and while I do, I think I will take another walk on the boardwalk!

YouTube Video

Friday, September 21, 2018

Amazon and Apple at a Trillion $: A Follow-up on Uncertainty and Catalysts!

In my last post, I looked at Apple and Amazon, as their market caps exceeded a trillion dollars, tracing the journey that they took over the last two decades to get to that threshold and valuing them  given their current standing. While you can check out the stories that I told and the details of my valuation in that post, I valued Apple at $200, about 9% less than the market price, and Amazon at abut $1255, about 35% lower than its market price. I concluded the post with a teaser, promising to come back with my decisions on whether I would sell my existing Apple shareholding and/or sell short on Amazon, after reviewing two loose ends. The first is to lay bare the uncertainties inherent in both valuations, to see if there is something in those uncertainties that I can use to make a better decision. The second is to evaluate whether there are catalysts that will convert the gap that I see between value and price into actual profits.

Facing up to Uncertainty
One of the recurrent themes in this blog is that we (as human beings) are not good at dealing with uncertainty. We avoid, evade and deny its existence, and in the process end up making unhealthy choices. When valuing companies, uncertainty is a given, a feature and not a bug, and traditional valuation models often give it short shrift. In fact, looking at my valuations of Apple and Amazon, you can see that the only place that I explicitly deal with uncertainty is in the discount rate, and even that process is rendered opaque, because I use betas and equity risk premiums to get to my final numbers. My cash flows reflect my expectations, and even in my moments of greatest hubris, I don't believe that I know, with precision, what will happen to Apple's revenue growth over time or how Amazon's operating margin will evolve in the future. So, why bother? In investing, you have no choice but to make your best estimates and value companies, knowing fully well that you will be wrong, no matter how much information you have and how good your models are. 

That said, it is puzzling that we still stick with point estimates (single numbers for revenue growth and operating margins) in conventional valuation, when we have the tools to bring in uncertainty  into our valuation judgments. While our statistics classes in college are a distant (and often painful) memory for most of us, there are statistical tools that can help us. While these tools may have been impractical even a decade ago, they are now more accessible, and when coupled with the richer data that we now have, we have the pieces in place to go beyond single value judgments. It is with this objective in mind that I recently updated a paper that I have on using probabilistic and statistical techniques to enrich valuation online, and you can get the paper by going to this link. Consider it a companion to another paper that I wrote a while back, dealing more expansively with uncertainty and healthy ways of dealing with it in investing and valuation.

Summarizing the probabilistic techniques that may help in valuation, I suggest three: (1) Scenario Analysis, for valuing companies that may have different valuations depending upon specific and usually discrete scenarios unfolding (for example a change in regulatory regimes for a bank or telecommunications company), (2) Decision Trees, for valuing companies that face sequential risk, i.e., you have to get through one phase of risk to arrive at the next one, as is the case with young drug companies that have new drugs in the regulatory pipeline and (3) Monte Carlo Simulations, the most general technique that can accommodate continuous and even correlated risks that you face in valuation, as is the case when you forecast revenue growth and operating margins for Apple and Amazon, in pursuit of their values.

Simulated Values: Apple and Amazon
Before delving into the simulations for Apple and Amazon, it is important that we set up the structure of the simulations first by first deciding what variables to build distributions around. While you may be tempted by the power of the tool to make every input (from risk free rates to terminal growth rates) into a distribution, my suggestion is that you focus on the variables that not only matter the most, but where you feel most uncertain. With Apple, the three inputs that I will build distributions around are revenue growth, operating margins and cost of capital. With Amazon, I will add a fourth variable to the mix, in the sales to invested capital, measuring how efficiently Amazon can deliver its revenue growth.

Apple: A September 2018 Simulation
I build around my core story for Apple, which is that it will be a slow growth, cash machine, deriving the bulk of its revenues, profits and value from the iPhone, but allow for uncertainty in each of my key inputs:
  1. Revenue growth: While my expected growth rate stays 3%, I allow for a range of growth rates from no growth (flat revenues) , if the iPhone's higher prices cost it signifiant market share) to 6% growth, which would require that Apple find a new growth source, perhaps from services or a new product.
  2. Operating Margin: In my story, I assumed that operating margin would decline to 25% (from  the current 30%) over the next five years. While I still feel that this is the best estimate, I allow for the possibility that competition will be stronger than expected (with margins dropping to 20%), at one end, and that Apple will be able to use its brand name to keep margins at 30%, at the other. 
  3. Cost of capital: My base case cost of capital is 8.20%, reflecting Apple's mix of businesses, but allowing for errors in my sector risk measures and changes in business mix, I build a distribution centered around 8.20% but with a small standard error (0.40%).  
Since I want to stay market neutral, taking no stand on either the level of interest rates or overall stock prices, I am leaving the ten-year bond rate and equity risk premium untouched. The results of the simulation are below:

Valuation & Simulation Output
Note that the median, mean and base case valuations are all bunched up at $200 and that the range in value, using the 10th and 90th percentiles, is tight ($176 to $229).

Amazon: A September 2018 Simulation
Moving from Apple to Amazon, my uncertainties multiply partly because my story is of a company that will move into any business where it believes its disruptive platform can deliver results, and there are very few businesses that are immune. Consequently, every input into the valuation is much more volatile, but I will focus on four:
  1. Revenue Growth: I used an expected growth rate for Amazon of 15% a year for the next 5 years, tapering down to lower levels in the future, to push revenues to $626 billion, ten years from now. While that is an ambitious target, Amazon has proved itself capable of beating sky high expectations before and it is plausible that the growth rate could be as high as 25% (which would translate to revenues of $1.13 trillion, ten years out). There is also the possibility that regulators and anti-trust enforcers may step in and restrain Amazon's growth plans, which could cause the growth rate to drop significantly to 5% (resulting in revenues of $330 billion in year 10).
  2. Operating Margin: While Amazon's margins have been on a slow, but steady, climb in the last few years, much of that improvement has come from the cloud services business, and the future course of margins will depend not only on how well Amazon can bring logistics costs under control but also on what new businesses it targets. I will stay with my base cash assumption of a target operating margin of 12.5%, but allow for the possibility that Amazon's margins will stay stagnant (close to today's margins of about 7%), at one extreme, and that there might be a new, very profitable business that Amazon can enter, pushing up the margins above 18%, at the other.
  3. Sales to Invested Capital: Currently, Amazon is an efficient utilizer of capital, generating $5.95 in revenues for every dollar of capital invested. While this will remain my base case, there may be future businesses that Amazon is targeting that may be more or less capital intensive than its current ones, leading to a significant range (3.95 for the more capital intensive - 7.95 to the less  capital intensive).
  4. Cost of Capital: I will stick with my base case cost of capital of 7.97%, with the possibility that that it could drop as Amazon's older businesses become profitable (but not by much, since the current cost of capital is close to the median for global companies) as well as the very real chance that it could go up significantly, if Amazon targets risky businesses in emerging markets for its growth.
Valuation & Simulation Output
The median value across the simulations is $1242, close to the base case valuation of $1,255. The range on value, using the 10th and 90th percentiles is $705 - $2,152, much wider than the range for Apple.

Lessons from Apple and Amazon Simulations
Simulations yield pretty pictures and if that is all you get out of them, it is time and energy wasted. There are lessons that we can eke out of the Apple and Amazon simulations that may help us in making more informed judgments:
  1. This is not about getting better estimates of value: If you are running simulations because you think they will give you more precise or better estimates of value than point estimate valuations, you will be disappointed. Since my input distributions are centered around my base case assumptions, and they should be, the median values across 100,000 simulations are close to my base case valuations for both Apple and Amazon.
  2. If it is a risk proxy, it is a very noisy and dangerous one: It is true that the spread of the distributions provides a measure of estimation uncertainty that you bring into your valuation. Using the Apple and Amazon simulations to illustrate, I face far greater uncertainty with my Amazon story than with my Apple story, and you can see it reflected in a larger range of value for the former. You may be puzzled that my cost of capital is lower for Amazon than for Apple, but that reflects the fact that much of the uncertainty that I face with Amazon is company-specific and should be buffered by other stocks in my portfolio. As a diversified investor, the variance in simulated values is a poor proxy for risk. However, if you are an investor who prefers concentrated portfolios, you can use the variance in simulated value as a measure of risk. 
  3. There can be no one margin of safety for all companies: I have written about the margin of safety before, often with skepticism, and one of my critiques has been with the way it is used in practice, where it is set at a fixed number for all companies. Thus, you will find value investors who use a margin of safety of 15% or 20% for all stocks, and the Apple and Amazon simulations show the danger in this practice. A 15% margin of safety for Apple may be too large, given how tightly values are distributed for the company, whereas the same 15% margin of safety may be too small for Amazon, with its wider band of values.
  4. Tails matter: Symmetry or the lack of it in distributions may seem like an inside statistics topic, but with simulated values, it has investment consequences. You can see that Apple's value distribution is  much more symmetric than Amazon's distribution, with the latter having a significant positive skew, reflecting a greater likelihood of big positive surprises in value, than negative ones. With companies with exposure to large and potentially catastrophic news stories (a large lawsuit or debt covenants), you can have value distributions that are negatively skewed.  In general, positive skewed distributions are better for (long) investors than negatively skewed ones, and the reverse is true for investors who are shorting a company.
I ran the simulations after my base case valuations suggested that Apple and Amazon were over valued, to see how they might affect my decision on whether to sell short on either company. The results are mixed.
  • While the simulations confirm my over valuations (no surprise there), with both companies, the current stock price is well within the realm of possibilities. While my base case valuation suggested that Apple was far less over valued (10%) than Amazon (55%), there is roughly a 15-20% chance that both companies are under valued, not over valued.
  • In addition, with Amazon, there is the added risk, if you are selling short, given the long positive tail on the distribution, that if I am wrong, the price I will pay will be much greater than if I am wrong with Apple.
The bottom line is that while Amazon seemed like a much better short selling target, after my base case valuations, because it was far more over valued than Apple, the simulations that I did on the two companies even out the scales, at least marginally. Apple is more over valued, but the probability of making money, assuming my valuations are on target is about the same with both stocks, and the downside of being wrong is far greater with Amazon than with Apple.

Value and Price: The Search for Catalysts
In the post that initiated this series, I looked at why crossing a trillion-dollar threshold may matter to investors, using the contrast between the value process and the pricing process. In effect, I argued that there can be a gap between value and price, and that even if you are right about your value judgment, you will make money only if the gap between the two closes:

Investment success thus rides not only on the quality of your value judgment, and how much faith you have in it, but on whether there are catalysts that can cause the gap to change. With companies, these catalysts can take different forms:
  1. Earnings reports: In their earnings reports, in addition to the proverbial bottom line (earnings per share), companies provide information about operating details (growth, margins, capital invested). To the extent that the pricing reflects unrealistic expectations about the future, information that highlights this in an earnings report may cause investors to reassess price. 
  2. Corporate news: News stories about a company's plans to expand, acquire or divest businesses  or to update or introduce new products can reset the pricing game and change the gap.
  3. Management Change/Behavior: A change in the ranks of top management or a managerial misjudgment that is made public can cause investors to hit the pause button, and this is especially true for companies that are bound to a single personality (usually a powerful founder/CEO) or derive their value from a key person. 
  4. Macro/ Government: A change in the macro environment or the regulatory overlay for a company can also cause a reassessment of the gap.
With all of these catalysts, there may be value effects (because the cash flows, growth and risk) as well, and it should also be noted that when the gap changes, it may not always close. In fact, these catalysts can sometime make a gap bigger, by feeding into pricing momentum.

As an investor, I look for catalysts when I invest, but I am even more intent on finding them, when I sell short than when I am long a stock. The reason for that divergence is that I am in far greater control of my time horizon, when I buy a stock, since, as long as I stay disciplined and retain faith in my value, only liquidity needs can cause me to sell. When I sell short, my time horizon is far less under my control, exposing me to timing risk. Put different, I can bet on a company being over valued, be right on my thesis, but still lose money on a short sale, because I am forced to close out my position, in the absence of a catalyst.

Going through the list of catalysts with Apple and Amazon, with both stocks approaching all-time highs, there is no obvious pricing trigger than I can point to, though my technical analyst friends will undoubtedly point to indicators that I did not even know existed. On the earnings front, the earnings reports for both companies are so heavily scripted to expectations that it would take a big surprise to reset stories, and I don't see that happening. In fact, I will predict that Amazon's earnings reports will continue to deliver double digit revenue growth and improving margins for the next few quarters, and investors will react positively, even though the growth may not be high enough or the margin improvement substantial enough to justify the market pricing. On the corporate news front, Apple's smart phone business model, with the pressure it puts on the company every year or two to reinvent itself, with the latest and the best, coupled with its big announcement events, creates catalyst moments. Looking back at Apple's ups and downs over the last few years, the triggers for substantial up and down movements on the stock have been new iPhone models doing better or worse than expected. In contrast, Amazon is remarkably low key in new product introductions, preferring to slip in under the radar. Both companies have well regarded and established CEOs, and neither company is personality-driven, making it unlikely that you will see management changes triggering big price changes. Finally, on the macro front, both companies face potential catalyst moments. For Apple, it is the possibility of a trade war with China, a huge market for its products and devices, and for Amazon, it is talk of regulatory restrictions and anti-trust actions that can constrain the company.  Since I cannot filibuster my way to a non-decision, I decided to compare my Apple and Amazon numbers/analysis, side by side:

I sold my Apple shares at $220, at the start of trading on Friday (9/21), but while I have not sold short any more shares. I have put in a limit (short) sell, if the price hits $230 (roughly my 90th percentile of value) in the near future. With Amazon, I sold short at $1950 at the start of trading on Friday (9/21).  the first time in twenty years that I have sold short on the company, and one reason that I am pulling the trigger is because I believe that the pushback from regulators and anti-trust enforcers will slow the company down in ways that no competitor ever could. I am doing so, with open eyes, since I believe that Amazon is in one of the best run companies in the world, adept at setting market expectations and beating them, and with a track record of taking short sellers to the graveyard. Time will tell, and I am sure that some of you reading this post will let me know, if my bet goes awry, but I don't plan to lose any sleep over this. 

YouTube Video

Trillion Dollar Posts


  1. Apple valuation and simulation results
  2. Amazon valuation and simulation results
(I use Crystal Ball, an add-on to Excel, for my simulations. If you don't have that extension (available only on the PC version), you cannot recreate my simulations, but you can download the program for a trial run on the Oracle website)

  1. Facing up to Uncertainty: Using Probabilistic Approaches in Valuation
  2. Living with Noise: Investing and Valuation in the Face of Uncertainty